Rockefeller Capital Management
ACIU icon

Rockefeller Capital Management’s AC Immune ACIU Stock Holding History

Rockefeller Capital Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.62K Hold
1,000
– – ﹤0.01% 4516
2026
Q2 		$2.38K Hold
1,000
– – ﹤0.01% 4392
2026
Q1 		$2.75K Hold
1,000
– – ﹤0.01% 4358
2025
Q4 		$3.14K Hold
1,000
– – ﹤0.01% 4205
2025
Q3 		$2.89K Buy
+1,000
New +$2.26K ﹤0.01% 4019

Other funds holding ACIU

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Rockefeller Capital Management's ACIU Position: Q3 2026 in Review

Rockefeller Capital Management held its AC Immune (ACIU) position steady in Q3 2026 at 1,000 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #4516.

Rockefeller Capital Management first reported a position in ACIU in Q3 2025 and has held it in 5 quarters since. The position peaked at $3.14K in Q4 2025. 27 funds tracked by Wall St. Rank hold ACIU as of Q3 2026.

  • Rockefeller Capital Management held 1,000 shares of AC Immune worth $2.62K as of Q3 2026.
  • Rockefeller Capital Management left its AC Immune share count unchanged in Q3 2026.
  • AC Immune made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #4516 holding.
  • Rockefeller Capital Management first reported a position in AC Immune in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's AC Immune position peaked at $3.14K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held AC Immune as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.